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Abstract
Pseudomonas aeruginosa is a Gram negative, opportunistic pathogen that uses the
overproduction of alginate, a surface polysaccharide, to form biofilms in vivo.
Overproduction of alginate, also known as mucoidy, affords the bacterium
protection from the host’s defenses and facilitates the establishment of chronic
lung infections in individuals with cystic fibrosis. Expression of the alginate
biosynthetic operon is primarily controlled by the alternative sigma factor AlgU
(AlgT/r22). In a nonmucoid strain, AlgU is sequestered by the transmembrane
antisigma factor MucA to the cytoplasmic membrane. AlgU can be released from
MucA via regulated intramembrane proteolysis by proteases AlgW and MucP
causing the conversion to mucoidy. Pseudomonas aeruginosa strain PAO579, a
derivative of the nonmucoid strain PAO1, is mucoid due to an unidentified
mutation (muc-23). Using whole genome sequencing, we identified 16 nonsynonymous and 15 synonymous single nucleotide polymorphisms (SNP). We then
identified three tandem single point mutations in the pilA gene (PA4525), as the
cause of mucoidy in PAO579. These tandem mutations generate a premature
stop codon resulting in a truncated version of PilA (PilA108), with a C-terminal
motif of phenylalanine-threonine-phenylalanine (FTF). Inactivation of pilA108
confirmed it was required for mucoidy. Additionally, algW and algU were also
required for mucoidy of PAO579. Western blot analysis indicated that MucA was
less stable in PAO579 than nonmucoid PAO1 or PAO381. The mucoid phenotype and high PalgU and PalgD promoter activities of PAO579 require pilA108,
algW, algU, and rpoN encoding the alternative sigma factor r54. We also
observed that RpoN regulates expression of algW and pilA in PAO579. Together,
these results suggest that truncation in type IV pilin in P. aeruginosa strain
PAO579 can induce mucoidy through an AlgW/AlgU-dependent pathway.

MicrobiologyOpen 2013; 2(3): 459–470
doi: 10.1002/mbo3.86
*Current address:
Department of Microbiology, University of
Virginia, Box 800734, Health System,
Charlottesville, Virginia, 22908

Introduction
Cystic fibrosis (CF) is a genetic disorder that results from
mutations in the CF transmembrane conductance regulator
gene (Rommens et al. 1989). These mutations cause a dis-

ruption in chloride transport of mucosal tissues resulting
in an accumulation of dehydrated mucus. This accumulation of mucus within the lungs prevents the removal of
infectious agents by interfering with the mucocilliary escalator (Chmiel and Davis 2003). This provides a hospitable

ª 2013 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
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environment for the adherence and cultivation of microbial
pathogens (Bauernfeind et al. 1987; Saiman et al. 1992). As
a result, individuals afflicted with CF are highly susceptible
to various bacterial infections including Pseudomonas aeruginosa (Govan and Deretic 1996). Pseudomonas aeruginosa
is a Gram negative, opportunistic pathogen that uses the
overproduction of alginate, a surface polysaccharide, to
form biofilms. The overproduction of alginate, also known
as mucoidy, is responsible for the establishment of chronic
infections, as well as an increased resistance to antibiotics
(Govan and Deretic 1996) and phagocytosis by macrophages (Leid et al. 2005) in CF patients. Chronic lung infections
with P. aeruginosa cause an increase in morbidity and mortality in individuals afflicted with CF (Lyczak et al. 2002),
and this transition from the nonmucoid to the mucoid
phenotype is a proven predictor of an overall decline in the
patient’s health (Henry et al. 1992).
Typically, constitutively mucoid strains arise in the lungs
of CF patients due to mutations in the mucA gene, which
encodes the inner membrane-spanning antisigma factor
(Martin et al. 1993; Boucher et al. 1997). MucA is a negative regulator of alginate overproduction because it sequesters AlgU (AlgT, rE, r22), the primary sigma factor
responsible for activation of the alginate biosynthetic
operon at the algD promoter (Wozniak and Ohman 1994).
Alternatively, the conversion to mucoidy can occur when
MucA is degraded by regulated intramembrane proteolysis
(Qiu et al. 2007). Proteolytic degradation is initiated
through cleavage of the C-terminal of MucA between the
alanine and glycine residues at position 136 by the serine
protease AlgW (Cezairliyan and Sauer 2009), anchored in
the periplasmic leaflet of the inner membrane, and followed
by the transmembrane protease MucP (YaeL) and the cytoplasmic proteases ClpX and ClpP (Qiu et al. 2007, 2008b;
Cezairliyan and Sauer 2009). The activation of AlgW, and
subsequent proteolysis of MucA, is thought to be in
response to extracellular stress, as well as the accumulation
of misfolded envelope proteins (Qiu et al. 2007; Wood and
Ohman 2009). We previously found that induction of a
small envelope protein called MucE causes mucoidy (Qiu
et al. 2007). MucE has an AlgW activation signal with a
C-terminal motif of tryptophan-valine-phenyalanine (WVF)
(Qiu et al. 2007). The MucE peptide has also been shown
to be a potent ligand to activate AlgW to degrade the periplasmic fragment of MucA (Cezairliyan and Sauer 2009).
Pseudomonas aeruginosa strain PAO579 was first generated in the 1970s through the isolation of mucoid variants
of PAO381 (Govan and Fyfe 1978), a nonmucoid derivative of the progenitor strain PAO1, following exposure to
carbenicillin. PAO579 is highly mucoid due to unclassified
mutation(s) that is referred to as muc-23 (Govan and Fyfe
1978). Previously, it has been shown that mucoidy in
PAO579 depends on the alternative sigma factor RpoN
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(r54) (Boucher et al. 2000). In this study, we used whole
genome sequencing to identify mutation(s) that cause the
mucoidy of PAO579. We identify three tandem mutations
in pilA that are responsible for the mucoid phenotype in
this strain. Moreover, the mucoid phenotype of strain
PAO579 is dependent upon AlgW, as well as AlgU and
RpoN. Our data suggests truncation of pilin induces
mucoidy in P. aeruginosa strain PAO579.

Experimental Procedures
Sequence analysis of PAO579
Methods and parameters used in the sequencing of
P. aeruginosa strain PAO579 were previously described
(Withers et al. 2012). The pilA108 gene of PAO579, which
was also sequenced by the Marshall University Genomics
Core Facility, has been separately deposited to GenBank
under the accession number KC692835.

Bacterial strains and growth conditions
Bacterial strains used in this study are indicated in
Table 1. Pseudomonas aeruginosa and Escherichia coli
strains were grown at 37°C in Lennox broth (LB), on LB
agar or Pseudomonas Isolation Agar (PIA). When indicated, the media was supplemented with carbenicillin,
gentamycin, tetracycline, kanamycin, and/or arabinose.

Construction of mutant strains
In-frame deletion of target genes algU (PA0762) and algW
(PA4446) in PAO579 was carried out through polymerase
chain reaction (PCR) amplification of the upstream and
downstream regions (500–1000 base pairs) flanking the target gene. Using crossover PCR, these upstream and downstream regions were fused and ligated into pEX100T-NotI.
A two-step allelic exchange procedure was used by first
screening the possible single cross-over mutants for carbenecillin resistance and sucrose sensitivity, then screening
for sucrose resistance and carbenecillin sensitivity. For construction of PAO579rpoN::TcR strain, rpoN (PA4462) was
amplified through PCR, cloned into pCR4-TOPO
Vector (Invitrogen, Carlsbad, CA) and transformed into E.
coli DH5a. In vitro transposon mutagenesis was performed
on the pCR4-TOPO-rpoN vector using the EZ::TN
<KAN-2> insertion kit (Epicentre Biotechnologies, Madison, WI). The mutant library was recovered and triparentally conjugated into en masse to PAO579. Mutants were
selected on PIA with tetracycline and screened for the
nonmucoid phenotype. PAO579pilA::aacC1 strain was
constructed using crossover PCR of 1000 bp upstream and
downstream fragments of pilA (PA4525) containing an

ª 2013 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.
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Table 1. Bacterial strains and plasmids used in this study.
Strain, plasmid
Escherichia coli
TOP10
Pseudomonas aeruginosa
PAO1
PAO381
PAO579
PAO579DalgU
PAO579DalgW
PAO579pilA::aacC1
PAO579rpoN::TcR
Plasmids
pCR4-TOPO
pRK2013
pHERD20T
pHERD20T-algW
pHERD20T-algW I239F
pHERD20T-pilA
pHERD20T-pilA108
pHERD20T-pilA-HA
pHERD20T-pilA108-HA
pHERD20T-oprF
pHERD20T-oprF-FTF
pHERD20T-HA-mucA
pUCP20T-PBAD rpoN
miniCTX-lacZ

miniCTX-PalgD lacZ
miniCTX-PalgU lacZ
pEX100T-NotI
pEX100T-DalgW
pEX100T-DalgU
pCR4-pilA::GmR

pLP170
pLP170-PalgU
pLP170-PalgD
pLP170-PpilA
pLP170-PalgW

Genotype, phenotype, description

Reference

DH5a derivative

Invitrogen

algU+mucA+; nonmucoid
algU+mucA+; nonmucoid, derived from PAO1
algU+mucA+muc-23; mucoid, derived from PAO381
mucA+muc-23, In-frame deletion of algU (PA0762); nonmucoid
algU+mucA+muc-23, In-frame deletion of algW (PA4446); nonmucoid
algU+mucA+muc-23, pilA::GmR (PA4525)
encoding a type IVa pilin precursor; nonmucoid
algU+mucA+muc-23, rpoN:: TcR (PA4462)
of the sigma factor RpoN (r54); nonmucoid

P. Phibbs*
J. Govan**
J. Govan**
This study
This study
This study

3.9-kb, ApR, KmR; TA cloning vector
KmR, Tra Mob ColE1
pUCP20T Plac replaced by 1.3-kb AflII-EcoRI fragment of araC-PBAD cassette
algW (PA4446) from PAO1 in pHERD20T; EcoRI/HindIII
algW (PA4446) from PAO579 in pHERD20T; EcoRI/HindIII
pilA (PA4525) from PAO1 in pHERD20T; EcoRI/HindIII
pilA (PA4525) from PAO579 in pHERD20T; EcoRI/HindIII
C-terminally tagged pilA-HA ending with the PKGCDN
motif cloned in pHERD20T; EcoR1/HindIII
C-terminally tagged pilA-HA ending with the DITFTF motif
cloned in pHERD20T; EcoR1/HindIII
oprF (PA1777) from PAO1 in pHERD20T; EcoRI/HindIII
oprF (PA1777) from PAO1 with FTF-motif fused to the
C-terminal; EcoRI/HindIII
N-terminally tagged HA-mucA in pHERD20T; EcoRI/HindIII
araC-PBAD-rpoN fusion in pUCP20; XbaI/HindIII
Gene delivery system used to fuse target genes to lacZ and
integrate onto the chromosome at the CTX phage att site
in Pseudomonas aeruginosa, TcR
Complete PalgD promoter (1525 bp upstream of ATG)
HindIII/BamHI in miniCTX-lacZ
Complete PalgU promoter (541 bp upstream of ATG)
EcoRI/HindIII in miniCTX-lacZ
Pseudomonas suicide vector with NotI restriction site fuse into
SmaI of pEX100T, sacB, oriT, CbR
1.4-kb fragment flanking the algW (PA4446) gene ligated into
pEX100T-NotI with in-frame deletion of algW
2.5-kb fragment flanking the algU (PA0762) gene ligated into
pEX100T-NotI with in-frame deletion of algU with 24 bp remaining.
1941 bp fragment contained 966 bp upstream of ATG and 975 bp
downstream of TAA with a MluI GmR cassette (750 bp) inserted 9 bp
before ATG of an in-frame deleted pilA ligated into pCR4-TOPO
8.3-kb, promoterless-lacZ, ApR, multiple cloning site
Complete PalgU promoter (541 bp upstream of ATG) fused
with lacZ in pLP170 BamHI/HindIII
Complete PalgD promoter (989 bp upstream of ATG) fused
with lacZ in pLP170 BamHI/HindIII
Complete PpilA promoter (500 bp upstream of ATG) fused
with lacZ in pLP170 BamHI/HindIII
Complete PalgW promoter (1000 bp upstream of ATG) fused with
lacZ in pLP170 BamHI/HindIII

This study

Invitrogen
(Figurski and Helinski 1979)
(Qiu et al. 2008a)
This study
This study
This study
This study
This study
This study
This study
This study
(Damron et al. 2009)
(Damron et al. 2009)
(Hoang et al. 2000)

(Damron et al. 2009)
(Damron et al. 2009)
(Damron et al. 2009)
(Qiu et al. 2007)
(Damron et al. 2009)
This study

(Preston et al. 1997)
This study
This study
This study
This study

*P. Phibbs, East Carolina University, Greenville, NC.
**J. Govan, University of Edinburgh, Scotland, U.K.
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internal MluI restriction site. This crossover PCR product
was cloned into the pCR4-TOPO vector and restriction
digested using MluI. A cassette containing a gentamycin
resistance marker restriction digested with MluI and ligated
into the pCR4-TOPO-pilA construct. Finally, the pCR4TOPO-pilA construct was triparentally conjugated and a
two-step allelic exchange procedure was used by first
screening for gentamycin resistance and carbenicillin resistance, then gentamycin resistance and carbenicillin sensitivity. All strains were amplified by PCR and sequenced to
confirm proper insertion or deletion of target genes.

T. R. Withers et al.

cultured at 37°C on three PIA plates supplemented with carbenecillin or carbenicillin and tetracycline. Bacterial cells
were harvested, resuspended in PBS and the OD600 was
recorded. The cells were permeabilized using toluene, and bgalactosidase activity was measured with results calculated
and reported in Miller Units (Miller 1972). One Miller Unit
equivalent to 1000 9(A420/ 1.75 9 A550/OD600/mL/min).
The reported values represent an average of three independent experiments with standard deviation. Student’s t-test
was performed to determine statistical significance.

Protein analyses
Plasmid construction and complementation
Plasmids used in this study are indicated in Table 1. Standard recombinant DNA cloning techniques were used in
the construction of all plasmids used in this study (Sambrook and Russell 2001). Briefly, oligonucleotide primers
were designed based on PAO1 sequence information and
synthesized by Eurofin MWG Operon. Primer sequence
information is available upon request. PCR amplifications
were done using EasyStartTM Micro 50 PCR Mixin-a-Tube (Molecular BioProducts, San Diego, CA) and
Taq DNA Polymerase (New England BioLabs, Ipswich,
MA). The pCR4-TOPO Vector (Invitrogen) was used as
an intermediary before ligation into the target vector. All
plasmids were purified using QIAprep Spin Miniprep Kit
(Qiagen Sciences, Hilden, Germany). All plasmid constructs were sequenced to confirm no mutations. Plasmids
were transformed into E. coli DH5a for all intermediate
cloning steps. Completed plasmids were triparentally conjugated into target P. aeruginosa strains using pRK2013 as a
helper strain (Figurski and Helinski 1979).

Alginate assay
Alginate was measured using the previously published carbazole reaction (Knutson and Jeanes 1968). Bacterial strains
were streaked in triplicate on PIA, and incubated at 37°C
for 24 h. The bacterial cells were scraped into 10 mL of
phosphate buffered saline (PBS) and the OD600 was recorded.
The amount of uronic acid was measured and compared
with an alginate standard curve made with D-mannuronic
acid lactone (Sigma-Aldrich, St. Louis, MO) in the range
0–100 lg/mL. The reported values represent an average of
three independent experiments with standard deviation.

Bacterial strains were grown at 37°C on PIA or LB media
supplemented with the appropriate antibiotics. Cells were
harvest and whole cell lysates were prepared using the ProteaPrep Cell Lysis Kit (Protea Biosciences, Morgantown,
WV) and the total protein content was quantified using Dc
Assay (Bio-Rad, Hercules, CA). Using a hemagglutinin
(HA) immunoprecipitation kit ((Thermo Fisher Scientific,
Rockford, IL), HA-tagged proteins were isolated by combining cell lysates with anti-HA agarose beads, incubating
overnight at 4°C, washing with a tris-buffered saline-Tween
solution, and eluting. About, 25 lg of protein samples were
boiled for 10 min in Tricine Sample Buffer (Bio-Rad) and
electrophoresed on a 16.5% Tris-Tricine gel (Bio-Rad).
Samples were then electro-blotted onto a HybondTM-P
polyvinylidene difluoride transfer membrane (GE Healthcare, Wauwatosa, WI). The membrane was blocked using
3% skim milk/PBS. Mouse monoclonal antibody for the
alpha subunit of RNA polymerase (Neoclone, Madison,
WI) and rat monoclonal antibody for HA (Roche Diagnostics, Indianapolis, IN) were used as primary antibodies.
Anti-type IVa pilin rabbit polyclonal antibodies were gifted
from the Lory laboratory (Harvard Medical School, Cambridge, MA). Horseradish peroxidase-labeled goat antimouse IgG, goat anti-rabbit or goat anti-rat IgG were used
as secondary antibodies. Primary and secondary antibodies
were diluted in 3% skim milk/PBS to 1:5000 and 1:10,000,
respectively. Western blot results were imaged using
enhanced chemiluminescence Advance Western Blotting
Detection Kit (Amersham; GE Healthcare) and UVP BioImagining Systems (Upland, CA). When necessary, blots
were stripped using 62.5 mmol/L Tris-HCl pH 6.8, 2%
SDS, 100 mmol/L b-mercaptoethanol for 10 min at 40°C.

Results
b-galactosidase activity assay
Pseudomonas strains carrying the plasmid pLP170 (empty
vector) or pLP170 containing PalgD, PalgU, PalgW, or PpilA or
PAO1 miniCTX-PalgU lacZ and miniCTX-PalgD lacZ with
pHERD20T, pHERD20T-pilA, or pHERD20T-pilA108 were
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PAO579 has polymorphisms in algW and
pilA
Using strain PAO1 as a reference genome, we performed
next-generation sequencing to determine the mutation(s)
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(muc-23) responsible for mucoidy in PAO579
(ALOF00000000) (Withers et al. 2012). As a result, 16 nonsynonymous and 15 synonymous single nucleotide polymorphisms (SNPs) were identified using two criteria: more
than 4 9 coverage and greater than 60% frequency (Table
S1). Consistent with previous phenotypic observations
(Stanisich and Holloway 1969; Govan and Fyfe 1978), we
detected mutations at loci rpsL (PA4268) and leuA
(PA3792), both corresponding to previous genetic and phenotypic markers in the parent strain PAO381 (Table 2).
Furthermore, PCR sequencing revealed that two genes,
algW (PA4446) and pilA (PA4525) contained SNPs in
PAO579 when compared with strain PAO381. Our results
showed a substitution of an adenine for a thymine at nucleotide 715 of the coding region of algW (PA4446), ultimately resulting in the exchange of phenylalanine for
isoleucine at amino acid 239 (I239F) in AlgW (Table 2).
We identify this mutation as algWI239F. We also observed
three tandem nucleotide substitutions (C ? T325,
A ? G326, G ? A327) in pilA (PA4525) creating a premature stop codon (TGA) (Table 2). The pilA gene encodes
for the protein precursor that constitutes the type IVa pilin.
Furthermore, analysis of these tandem mutations at nucleotides 352–327 revealed a truncation in PilA from 149 to 108
amino acids (Fig. S1). We identify this mutation as pilA108.
We hypothesized that one, or both of these mutations
could be responsible for mucoidy in PAO579.

algW and algU are required for alginate
overproduction in strain PAO579
AlgW is the first in a cascade of proteases responsible for
the degradation of MucA (Wood et al. 2006; Cezairliyan
and Sauer 2009; Wood and Ohman 2009). To determine
if algW is required for mucoidy in PAO579, we deleted
algW and observed a decrease in alginate production and
a conversion to the nonmucoid phenotype (Fig. 1). Next,
we cloned algW and algWI239F into the shuttle vector
pHERD20T containing the arabinose-inducible PBAD promoter (Qiu et al. 2008a). We observed that the expression

of algW in trans restored mucoidy to PAO579DalgW
(Fig. 1). Similarly, we observed that expression algWI239
in trans could restore mucoidy in PAO579, however we
did not observe a significant difference in the amount of
alginate produced (Fig. 1). More importantly, algWI239F
did not induce mucoidy in PAO1DalgW (Fig. 1). These
data indicate that AlgW is required for mucoidy in
PAO579, however the I239F mutation is not responsible
for inducing mucoidy in PAO579.
Previous reports suggested that algU was not required
for alginate overproduction of strain PAO579 (Boucher
et al. 2000). However, our data showing that AlgW is
required for mucoidy suggests that MucA degradation, and
subsequently, the release of AlgU, is occurring in PAO579.
If so, expression of MucA would result in a loss of mucoidy. To test this, mucA was expressed from using both
pHERD20T and the low-copy number Ptac vector (Graupner and Wackernagel 2000), and loss of mucoidy was
observed (data not shown). Additionally, we observed that
deletion of algU from PAO579 resulted in a loss of mucoidy
(Fig. 1). Expression of algU in trans in PAO579DalgU
restored mucoidy (data not shown). These data suggest that
AlgU is required for alginate production in PAO579.

Expression of pilA108 induces mucoidy in
PAO579
Since our data suggested that algWI239F is not responsible
for the induction of mucoidy, we next examined the role of
pilA108 in the regulation of alginate overproduction in
PAO579. Based on our sequence analysis, we determined
that pilA108 encodes for ~11 kDa protein. Western blot
analysis using anti-PilA polyclonal antibodies revealed a
lack of the full length pilin protein in PAO579 (Fig. S2A).
Additionally, HA-tagged PilA108 was only detected with
Western blot analysis after immunopurification (Figs. S2B
and C). Furthermore, analysis of our sequence data
revealed that the C-terminal of PilA108 consists of a three
amino acid motif of phenylalanine-threonine-phenylalanine (FTF) (Fig. S1). Previously, we reported that the C-

Table 2. Summary of sequencing results.

SNP

Genome position

Nucleotide
change

SNP position
(gene size)

1
2
3

4771865
4251149
4980548
5069207
5069206
5069204

T?C
G?A
A?T
C?T
A?G
G?A

263
322
715
325
326
327

4

(372)
(1779)
(1170)
(450)
(450)
(450)

Locus tag

Gene

Gene product

Protein change

Domain

PA4268
PA3792
PA4446

rpsL
leuA
algW

K88R+
E108K+
I239F

16S Binding
DRE_TIM_LeuA
Trypsin-L2 Loop

PA4525

pilA

30S ribosomal protein S12
2-isopropylmalate synthase
DegS-like MucA Protease
Type IVa pilin precursor
Type IVa pilin precursor
Type IVa pilin precursor

***

C-terminal FTF

SNP, synonymous single nucleotide polymorphisms; FTF, phenylalanine-threonine-phenylalanine.
***Stop Codon.
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Figure 1. Alginate production by Pseudomonas aeruginosa strains PAO1, PAO579, and PAO579 mutants. All strains were grown on
Pseudomonas Isolation Agar (PIA) plates for 24 h at 37°C then for 24 h at room temperature. The alginate was collected and measured using the
carbazole assay. The values are reported as mean  standard deviation of three independent experiments. M, Mucoid; NM, Nonmucoid.

Table 3. Complementation analyses of pilA, pilA108, oprF, and oprF-FTF.
Pseudomonas strains

Vector control

pilA

pilA108

oprF

oprF-FTF

PAO1
PAO1DalgW

NM (3.6  0.4)
NM (6.7  3.2)

NM (11.7  1.6)
NM (4.4  4.4)

M (52.7  7.1)
NM (5.2  3.3)

NM (6.3  5.8)
NM (4.7  1.9)

M (40.8  6.8)
NM (7.4  1.2)

NM, nonmucoid; M, mucoid; FTF, phenylalanine-threonine-phenylalanine. pHERD20T was used in this study. All strains were grown on PIA supplemented with 300 lg/mL carbenicillin and 0.1% (w/v) L-arabinose at 37°C for 24 h. The alginate measurements for three independent experiments
are represented as (Mean lg of Alginate/mL/OD600  standard deviation).

terminal motif WVF found on the small envelope protein
MucE can induce mucoidy through the activation of AlgW
(Qiu et al. 2007). Based on this information, we hypothesized that the truncated pilA108 could induce mucoidy
through AlgW. We tested this hypothesis by first inactivating pilA in PAO579 through the insertion of a gentamycin
cassette (PAO579pilA::aacC1). We observed a decrease in
alginate production and a conversion to the nonmucoid
phenotype in PAO579pilA::aacC1 (Fig. 1). Next, we complemented these experiments by cloning the wild-type pilA
and pilA108 into pHERD20T containing the arabinoseinducible PBAD promoter and expressed them in trans. We
observed that expression of pilA108 increased alginate production inducing mucoidy in PAO579pilA::aacC1 (Fig. 1),
while expression of pilA wild-type did not (Fig. 1). Similar
results were also observed in PAO1 (data not shown). We
also observed that the expression of pilA108 did not confer
mucoidy in PAO579DalgW, suggesting that PilA108 acts
through AlgW. To confirm whether the FTF-motif found
in PilA108 can induce mucoidy via AlgW, we cloned the
major outer membrane porin precursor oprF (PA1777) and
oprF with the addition of the FTF motif to its C-terminal
(oprF-FTF) into pHERD20T. Next, we conjugated this
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construct, as well as pHERD20T-pilA and pHERD20TpilA108 into PAO1 and PAO1DalgW. After incubating in
the presence of 0.1% (w/v) arabinose, we observed oprFFTF and pilA108 increased alginate production and conferred mucoidy in PAO1 (Table 3). Expression of oprF did
not induce mucoidy in PAO1, which is consistent with our
previously published results (Qiu et al. 2008a). Expression
of pilA did not induce mucoidy in PAO1. As expected, we
did not observe any phenotypic change when pilA, pilA108,
oprF, oprF-FTF were expressed in PAO1DalgW (Table 3).
These results suggest that the FTF-motif found at the Cterminal of PilA108 can activate mucoidy through AlgW.

pilA108 and algW are required for
proteolytic degradation of MucA
As expression of pilA108 required algW to confer mucoidy
in PAO579, we hypothesized that the activation of alginate
production was due to increased MucA degradation. In
order to test this hypothesis, we measured the degradation
of MucA by expressing an N-terminally HA-tagged MucA
(Damron et al. 2009) via the PBAD arabinose-inducible
promoter (pHERD20T-HA-mucA) in PAO1, PAO381,
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PAO579, PAO579pilA::aacC1 and PAO579DalgW. All
strains were cultured on PIA plates supplemented with
carbenicillin and 0.1% arabinose. Western blot analysis of
PAO1 and PAO381 showed similar levels of full length
HA-MucA, although we detected greater accumulation of
protein at 20 kDa and 10 kDa in PAO381 (Fig. 2, Lane 1
and 2). We detected a decrease in full length HA-MucA
and increase in lower molecular weight products
(~10 kDa) in PAO579 when compared with all other test
strains (Fig. 2, Lane 3). We also detected similar amounts
of full length HA-MucA in PAO579pilA::aacC1 and
PAO579DalgW as PAO381 (Fig. 2, Lane 4 and 5). These
results suggest that there is an increase in MucA degradation in PAO579 when compared with its progenitor strains
PAO1 and PAO381. Additionally, pilA108 and algW are
required for increased MucA degradation in PAO579.

Increased transcriptional activity at the
PalgD and PalgU promoters in PAO579
requires pilA108, algW, algU, and rpoN
Based on our Western blot analyses of MucA, we hypothesized that deletion of pilA108, algW, and algU would

Figure 2. Western blot analysis of N-terminally tagged HA-MucA in
PAO1, PAO381, PAO579, PAO579pilA::aacC1, and PAO579DalgW.
Shown are representative panels of three independent experiments. All
strains were grown on Pseudomonas Isolation Agar (PIA) plates
supplemented with carbenicillin and 0.1% arabinose for 24 h at 37°C
then for 24 h at room temperature. Cell lysates were prepared and
25 lg of total protein was loaded for each sample for SDS-PAGE
electrophoresis. Following transfer, the membrane was immunoblotted
with primary rat anti-HA and secondary horseradish peroxidase-labeled
goat anti-rat IgG. Protein levels were categorized as High MW
(>20 kDa) or Low MW (<20 kDa), normalized to PAO1 pHERD20THA-mucA, and presented as relative means  standard deviations.
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result in a decrease in transcriptional activity for the alginate biosynthetic operon. To test this, we measured
promoter activity by fusing the entire PalgD promoter to
lacZ in the plasmid pLP170 (Preston et al. 1997), and
performing a Miller assay (Miller 1972). We observed a
significant increase in PalgD activity in PAO579 as compared with its progenitor strains PAO1 and PAO381
(Fig. 3). We also observed a significant decrease in PalgD
activity in the pilA108, algW, and algU mutants in
PAO579 (Fig. 3). As the expression of AlgU gene is autoregulated, it is possible to indirectly measure the release
of AlgU following MucA degradation using a b-galactasidase promoter fusion assay. Similar to our analysis of the
algD promoter, we used the plasmid pLP170 to fuse the
entire algU promoter region to lacZ, and performed a
Miller assay. Similar to our algD promoter analysis, we
observed a significant increase in PalgU activity in PAO579
compared to PAO1 and PAO381, and a significant
decrease in PalgU activity in the pilA108, algW, and algU
mutants (Fig. 3).
Additionally, we measured the effect of wild-type pilA
and pilA108 expression on merodiploid strains carrying
PalgD and PalgU fused with the lacZ reporter gene (Damron et al. 2009) in the presence of the shuttle vector
pHERD20T, pHERD20T-pilA, and pHERD20T-pilA108.
After induction with 0.1% arabinose, we observed that
expression of pilA108 caused significant increase in PalgD
activity as compared to the vector control and wild-type
pilA (Fig. 4). There was no significant difference in PalgD
activity between the vector control and pilA wild-type

Figure 3. The b-galactosidase activity of the PalgD and PalgU promoter
fusions was measured using the pLP170-PalgD lacZ and pPLP170PalgU lacZ reporter constructs. Each strain was on incubated at 37°C
on Pseudomonas Isolation Agar (PIA) plates supplemented with
300 lg/mL of carbenicillin. The values for the mean  standard
deviation are shown as relative expression, and are representative of
three independent experiments. Asterisks indicate statistical
significance (*P < 0.05).
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(A)

(B)

Figure 4. The b-galactosidase activity of the algD and algU
promoters was measured using the miniCTX-PalgD lacZ and miniCTXPalgU lacZ reporter constructs integrated to att site in PAO1 and
pHERD20T, pHERD20T-pilA or pHERD20T-pilA108 were conjugated
using the helper plasmid pRK2013. Each strain was incubated at 37°C
on Pseudomonas Isolation Agar (PIA) plates supplemented with
tetracycline, carbenicillin, and 0.1% arabinose. The values for the
mean and standard deviation are shown as relative expression, and
are representative of three independent experiments. Asterisks
indicate statistical significance (*P < 0.01; **P < 0.0005).

(Fig. 4). A similar trend was observed when measuring
the PalgU promoter activity (Fig. 4).
Previously, it was reported that the alternative sigma
factor RpoN was also required for alginate production in
PAO579 (Boucher et al. 2000). Consistent with these
findings, we observed that inactivation of rpoN in
PAO579 (PAO579rpoN::TcR) resulted in a significant
decreases in activity at the algD and algU promoters when
compared to PAO579 (Fig. 3). Interestingly, overexpression of rpoN using pHERD20T failed to induce mucoidy
in PAO579pilA::aacC1 and PAO579DalgU, suggesting that
RpoN regulates mucoidy in PAO579 upstream of PilA
and AlgU. Additionally, we performed Western blot analysis to measure the level of RpoN in PAO1, PAO579, and
PAO381. We found the level of RpoN is comparable in
these three strains (data not shown). RpoN regulates global gene expression of many motility genes in nonmucoid
strains of P. aeruginosa (Dasgupta et al. 2003). Likewise,
it has been shown that RpoN is responsible for transcription of pilA through the PilS/PilR two-component regulatory system (Hobbs et al. 1993). Deletion of rpoN from a
mucoid strain resulted in dysregulation of ~20% of the
genome (Damron et al. 2012). In this study, it was also
shown that RpoN may be involved in expression of algW
(Damron et al. 2012). Expression of pilA108 in PAO579
rpoN::TcR did not restore mucoidy indicating rpoN may
have multiple roles in alginate overproduction in strain
PAO579. We hypothesized that the inability of pilA108 to
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Figure 5. The b-galactosidase activity of the algW (A) and pilA
promoters (B) was measured using the pLP170-PalgW lacZ and
pPLP170-PpilA lacZ reporter constructs. Each strain was incubated at
37°C on Pseudomonas Isolation Agar (PIA) plates supplemented with
300 lg/mL of carbenicillin. The values for the mean and standard
deviation are representative of three independent experiments. The
measurement for PpilA activity is presented in log Miller Units.
Asterisks indicate statistical significance (*P < 0.005; **P < 0.0005).

confer mucoidy in PAO579rpoN::TcR could be due to
RpoN role driving transcription at both the pilA and
algW promoters. We tested this hypothesis by measuring
the level of promoter activities of PpilA and PalgW. The
level of PpilA and PalgW activity between strains PAO1 and
PAO381 were similar; however, we observed a significant
increase in activity in PAO579 at both promoters sites
(Figs. 5A and B). The level of promoter activity for both
PpilA and PalgW fell below the threshold for detection in
PAO579rpoN::TcR (Figs. 5A and B). These results are
consistent with previous reports, stating that RpoN drives
transcription of pilA and algW in PAO579. Together,
these results suggest that RpoN regulates mucoidy in
PAO579 upstream of pilA108, algW, and algU.

Discussion
Generally speaking, there are two types of mucoid isolates
found in CF sputum samples: those with mutations
mapped within the mucABCD cluster (Schurr et al. 1996;
Boucher et al. 1997; Anthony et al. 2002), and those with
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undefined mutations mapped outside of the mucABCD
cluster. While it is known that mucA mutants are associated with chronic infections, it is not clear what mucoidrelated genotypes are present in those early colonizing
strains. In this study, we used whole genome sequence
analysis to identify the unknown positive regulator(s) of
alginate production in P. aeruginosa strain PAO579 (muc23), an isogeneic derivative of PAO1. We identified three
tandem point mutations in the pilA gene resulting in a
premature stop codon. These alterations cause a truncation in the major subunit of type IVa pilin at amino acid
108. This truncated version of PilA reveals a C-terminal
primary amino acid sequence of FTF, which functions as
a signal to activate alginate overproduction through the
proteolytic degradation of MucA. We observed that the
transcriptional activity at the algD and algU promoters is
increased in PAO579, while inactivation of algW, algU,
rpoN, and the truncated pilA causes a significant decrease
in activity at these promoters. Also of note, we determined that the sigma factor RpoN regulates transcription
at both the pilA and algW promoters in PAO579.
Initially we identified a nonsynonymous mutation in
algW of PAO579 (algWI239F). However, this mutation did
not have an impact on AlgW activity (Fig. 1). Deletion of
algW in PAO579 did result in a loss of mucoidy, however
expression of algW and algWI239F in trans from the PBAD
promoter did not result in a significant difference in alginate overproduction (Fig. 1). The amino acid substitution
occurs in a nonconserved site next to the L2 loop
(Cezairliyan and Sauer 2009) which may explain why we
did not observe any significant difference in the amount
of alginate produced. Taken together, these results indicate that the activity of AlgWI239F is not increased in
comparison to wild type AlgW in activating alginate overproduction. However, the requirement of AlgW for
mucoidy does implicate the release of AlgU due to proteolytic degradation of MucA. Western blot analysis of the
HA-MucA confirms that there is increase in lower molecular weight products in PAO579 as compared with PAO1,
PAO381,
PAO579pilA::aacC1,
and
PAO579DalgW
(Fig. 2). These results indicate that there is increased
MucA degradation in PAO579.
We observed that the deletion of algU resulted in a loss
of mucoidy in PAO579 (Fig. 1). In Boucher et al. 2000,
RpoN was shown to be involved in driving transcription
at PalgD. In this same study, algU was inactivated by an
insertion of a tetracycline resistance cassette and observed
to not be essential for the mucoid phenotype of PAO579.
In our study, as AlgW was required for the mucoid phenotype of PAO579, degradation of MucA, and transcriptional activity at the PalgD promoter (Figs. 1, 2 and 3), we
hypothesized that AlgU was most likely required for the
mucoid phenotype of PAO579. We then in-frame deleted
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algU from PAO579 and observed this strain to be nonmucoid (Fig. 1). We were also able to complement this
strain by expressing algU in trans and observed a return
to the mucoid phenotype (data not shown). In this
respect, the essential difference from our study here and
the Boucher et al. study is that algU was completely
deleted from PAO579 in our study. Although our data
argues that algU is required, it also confirms that RpoN is
required for mucoidy in PAO579. However, overexpression of RpoN in PAO579pilA::aacC1 and PAO579DalgU
did not confer mucoidy. Additionally, we observed that
rpoN may be regulating alginate production upstream of
AlgU through controlling expression of algW and pilA
(Fig. 5). All together these data suggest that RpoN act
upstream of pilA108 and algU in regulating mucoidy in
PAO579. This pathway is illustrated in Figure 6, RpoN
drives transcription of algW and pilA108. PilA108 activates
AlgW to begin proteolytic degradation of MucA. Upon
release, AlgU drive transcription of the alginate biosynthetic and algUmucABCD operons via the PalgD and PalgU,
respectively.
The pilA gene encodes for the type IV pilin precursor
which is responsible adhesion to respiratory epithelial
cells (Doig et al. 1988), as well as surface translocation or
twitching motility (Mattick 2002). Previously, Yang et al.
(2010) showed that two missense mutations in pilA of
Myxococcus xanthus can cause membrane accumulation of

Figure 6. Schematic diagram of summarizing the induction of
alginate production and mucoid conversion by PilA in Pseudomonas
aeruginosa strain PAO579. The sigma factor RpoN is required for
transcription of pilA108 and algW. PilA108 is transported to the
periplasm, where it activates the periplasmic protease AlgW which
proteolytically degrades the antisigma factor MucA releasing the
sequestered sigma factor AlgU. AlgU drives transcription of the
alginate biosynthetic operon via the algD promoter.
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pili, resulting in a decrease in exopolysaccharide production. Similarly, the current study shows that three tandem
mutations in pilA can affect exopolysaccharide production; however we observed an overproduction in alginate
(Fig. 1). An increased frequency of mutants has been
shown to occur in P. aeruginosa strains with mutations in
the DNA mismatch repair system such as mutS (Oliver
et al. 2000). Additionally, alterations in the mutL and
uvrD have also been shown to result in a mutator phenotype (Oliver et al. 2002). However, we did not detect any
polymorphisms at these loci, suggesting that the frequency at which three tandem point mutations may occur
is quite low. Although the C-termini of pilin displays a
high diversity, those found in CF isolates tend to cluster
together into one phylogenic group (Kus et al. 2004).
Through BLAST searches, we identified 6 clinical isolates
that carry an internal FTF motif (Fig. S3). It is known
that mucoid mutants are selected for in the CF lung. Our
study suggests that mutations can arise in envelope proteins, such as pilA, and induce alginate overproduction.
Because, regulated proteolysis is controlled by the AlgW
protease and envelope proteins, we wonder if a treatment
strategy targeting these proteins could block alginate overproduction and allow for better clearance of chronic P.
aeruginosa infections.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Diagram showing the predicted structure for
PAO1 PilA and PAO579 PilA. (A) Base pair substitutions
in the pilA gene in PAO579 result in a premature STOP
codon and a truncation in the PilA protein from 149
amino acid residues and molecular weight of 15.5 to 108
amino acid protein with a molecular weight of 11.2 kDa.
PAO579 PilA has an activating domain (b2) that is
responsible for the positive regulation of alginate production which consists of a phenylalanine-threonine-phenylal-
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anine (FTF) motif at its C-terminal. (B) The truncation of
PAO579 PilA at amino acid 108 also results in the loss of
the b3 and b4 antiparallel sheets, as well as revealing the
activating domain in the b2 sheet.
Figure S2. Western blot analysis of PilA108 (A) PAO579
and PAO1 were grown at 37°C on PIA. Cellular protein was
harvested and was subjected to SDS-PAGE electrophoreses,
membrane transfer, and probed with anti-Pilin polyclonal
antibodies. (B) PAO1 cells containing pHERD20T (Vector),
pHERD20T-pilA-HA and pHERD20T-pilA108-HA were
grown at 37°C on PIA plates supplemented with carbenicillin and 0.1% arabinose. Cellular protein was harvested and
was subjected to SDS-PAGE electrophoreses, membrane
transfer, and probed with anti-HA monoclonal antibody.
(C) PAO1 pHERD20T and pHERD20T-pilA108-HA was
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cultured on PIA plates supplemented with carbenicillin and
0.1% arabinose. Cellular protein was harvested then purified
using high affinity anti-HA immunoprecipitation and analyzed using SDS-PAGE electrophoresis, membrane transfer,
and probed with anti-HA monoclonal antibody.
Figure S3. Basic Local Alignment Search Tool (BLAST) for
the C-terminal of the PilA. The red arrow identifies the location of the truncation revealing the phenylalanine-threonine-phenylalanine (FTF) motif found in PAO579. The
black arrows identify clinical isolates containing the same
internal motif with NCBI accession GI number and strain
name.
Table S1. Complete summary of sequencing results for
PAO579.
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